VAXDIGM
Seoul · Founded 2021
About VAXDIGM
VAXDIGM focuses on the development of advanced vaccines and future vaccines.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: http://www.vaxdigm.com
- Phone: 82 70-4355-2312
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vaxdigm-51650 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.